Markets:

Overview

News

Currencies

International

Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

85.98 +0.22 (+0.25%)

Streaming Delayed Price Updated: 9:41 AM EST, Jan 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

July 29, 2025

From CG Oncology Inc.

Via GlobeNewswire

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

September 11, 2024

From ANI Pharmaceuticals, Inc. and Alimera Sciences, Inc.

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)

July 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR), PlayAGS, Incorporated (NYSE - AGS), RBAZ Bancorp, Inc. (OTCPK - RBAZ)

July 01, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Records 52-Week High Wednesday Morning

August 23, 2023

Via Investor Brand Network

ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference

May 22, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 16, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity

May 15, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock

May 12, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock

May 11, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

May 08, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET

April 27, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

April 26, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP

April 24, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP

April 04, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance

March 09, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET

February 22, 2023

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP

December 19, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP

November 28, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP

November 16, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues

November 09, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET

October 24, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer

September 12, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

August 30, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP

August 29, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP

August 16, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel

August 08, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP

August 03, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC

July 28, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET

July 25, 2022

From ANI Pharmaceuticals, Inc.

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.